The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells
Endocrine Related Cancer (2011) - Comments
pubmed: 21551258  doi: 10.1530/erc-11-0045  issn: 1479-6821  issn: 1351-0088 

Giovanni Luca Gravina, Francesco Marampon, Foteini Petini, Leda Biordi, David Sherris, Emmanuele A Jannini, Vincenzo Tombolini, Claudio Festuccia